WebFind the latest Cingulate Inc. (CING) stock quote, history, news and other vital information to help you with your stock trading and investing. WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), today announced that it has moved the location of …
In the News - Cingulate Inc
WebDec 8, 2024 · Cingulate Therapeutics (CTx) is a privately held, clinical-stage biopharmaceutical company focused on the development of products for the treatment … WebApr 3, 2024 · Cingulate Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry. Cingulate Therapeutics's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and … sonny\u0027s buff n dry
Private Life Sciences Company Call Series - oppenheimer.com
WebCingulate Therapeutics Primary Sponsor contact: Holly Mitzel Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS 66205 E: [email protected] P: 913-942-2304 Secondary Sponsor contact: Matt Brams, MD Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS … WebApr 6, 2024 · Alterity Therapeutics NASDAQ:ATHE; View All Competitors. Insiders & Institutions. HighTower Advisors LLC Bought 34,425 shares on 2/9/2024 Ownership: … WebJun 24, 2024 · Virtual. We are pleased to invite you to a virtual call series highlighting the next generation of life sciences private companies from Monday, June 29 th – Thursday, July 2 nd, 2024. We will be hosting the companies for 35 minute presentations with time for Q&A over the four days. sonny\u0027s blues short story theme